Jade Biosciences (JBIO) Stock Price, Quote, News & History | Benzinga

Jade Biosciences Inc (JBIO) Stock Price, Quote, News & History

JBIONASDAQ

Trade with Public

Trade with Public

$21.02

-0.27-1.27%

Last update: Aug 28, 9:30 AM

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$21.04

Close

-

Volume / Avg.

123.48K / 1.11M

Day Range

$20.82 - $21.40

52 Wk Range

6.91 - 28.00

Market Cap

$1.34B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

18.57%

Days to Cover

10.15

Recent Jade Biosciences Inc News

Stock Market Today: S&P 500, Dow, Nasdaq Futures Fall As House Challenges Trump's Military Authority— Broadcom, CrowdStrike In Focus (UPDATED)

(Editor’s note: The future prices of benchmark tracking ETFs and the headline were updated in the story.) U.S. stock futures declined on Thursday after a lower close on Wednesday, as the Nasdaq 100, Dow Jones and S&P 500 fell.

Rishabh Mishra

Ciena, Docusign And 3 Stocks To Watch Heading Into Thursday

Stocks to watch: CIEN, DOCU, LULU, report earnings today. MRAAF introduces world's first 100Vdc 2.2μF chip MLCC for auto safety.

Avi Kapoor

Why Is Jade Biosciences Stock Trading Lower On Monday?

Jade Biosciences reports Phase 1 JADE101 data showing sustained IgA reductions in IgAN, while analyst addresses ADA concerns and timeline expectations.

Vandana Singh

Taylor Morrison Home Surges On Berkshire Hathaway Acquisition, Joins Elmet Group And Other Big Stocks Moving Higher In Monday's Session

U.S. stock futures up, Nasdaq surges 0.35%, with Taylor Morrison's buyout announcement. Other pre-market gainers include ELMT, PURR, and SPCE.

Avi Kapoor

XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday

U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acquire XOMA for $39.00/share. Other big gainers: MANE, ORKA, OGN, XE, PLBL, SLS, ANAB, EVH, IHRT, RPAY, JBIO, BEAM.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-123.51M

Investing Cash Flow (TTM)

-352.97M

Financing Cash Flow (TTM)

362.89M

Free Cash Flow (TTM)

-123.57M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-113.59M

Analyst Trends and Forecast

4

Mar

1

Apr

3

May

4

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$894.05M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.08

Earnings Yield % (TTM)

-5.02%

Earnings Yield % (FWD)

-11.50%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$6.92

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$107.25M

Debt to Equity

0.00

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$21.04

Close

-

Volume / Avg.

123.48K / 1.11M

Day Range

$20.82 - $21.40

52 Wk Range

6.91 - 28.00

Market Cap

$1.34B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

18.57%

Days to Cover

10.15

About

Sector

Health Care

Industry

Biotechnology

Jade Biosciences Inc is a clinical-stage biotechnology company focused on developing therapies for autoimmune diseases. Its flagship candidate, JADE101, targets the cytokine APRIL and is in a Phase 1 clinical trial for the treatment of immunoglobulin...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Jade Biosciences (JBIO) stock?

A

You can purchase shares of Jade Biosciences (NASDAQ:JBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Jade Biosciences (JBIO) competitors?

A

Other companies in Jade Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Jade Biosciences (JBIO) stock?

A

Jade Biosciences has a consensus price target of $46.83.

Q

What is the current price for Jade Biosciences (JBIO)?

A

The stock price for Jade Biosciences (NASDAQ: JBIO) is $21.02 last updated August 28, 2026 at 9:30 AM EDT.

Q

Does Jade Biosciences (JBIO) pay a dividend?

A

There are no upcoming dividends for Jade Biosciences.

Q

When is Jade Biosciences (NASDAQ:JBIO) reporting earnings?

A

Jade Biosciences does not have any upcoming earnings scheduled.

Q

Is Jade Biosciences (JBIO) going to split?

A

There is no upcoming split for Jade Biosciences.

Q

What sector and industry does Jade Biosciences (JBIO) operate in?

A

Jade Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.